Home | Sitemap | Submit Content | Contact Us   
imageHome : Latest News : ADVENTRX to Present Complete ANX-530 Pharmacokinetic Data at the 2008 ...

ADVENTRX to Present Complete ANX-530 Pharmacokinetic Data at the 2008 ...

  • email Email to a friend
  • print Print version

Did you enjoy this article?

(total 0 votes)
Try our own cheap Booking Service275 times read : Adjust font size: Decrease font Enlarge font
image

Forbes - SAN DIEGO, Feb. 7 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX), announced today that complete pharmacokinetic data from the Company's marketing-enabling bioequivalence clinical study of ANX-530 (vinorelbine emulsion) has been ...

Read this article...



Post your comment comment Comments (0 posted)

copyright